Discovery of widespread type I and type V CRISPR-Cas inhibitors ND Marino, JY Zhang, AL Borges, AA Sousa, LM Leon, BJ Rauch, ... Science 362 (6411), 240-242, 2018 | 258 | 2018 |
A bacteriophage nucleus-like compartment shields DNA from CRISPR nucleases SD Mendoza, ES Nieweglowska, S Govindarajan, LM Leon, JD Berry, ... Nature 577 (7789), 244-248, 2020 | 184 | 2020 |
A compact Cascade–Cas3 system for targeted genome engineering B Csörgő, LM León, IJ Chau-Ly, A Vasquez-Rifo, JD Berry, C Mahendra, ... Nature methods 17 (12), 1183-1190, 2020 | 159 | 2020 |
Mobile element warfare via CRISPR and anti-CRISPR in Pseudomonas aeruginosa LM Leon, AE Park, AL Borges, JY Zhang, J Bondy-Denomy Nucleic acids research 49 (4), 2114-2125, 2021 | 71 | 2021 |
How bacteria control the CRISPR-Cas arsenal LM Leon, SD Mendoza, J Bondy-Denomy Current opinion in microbiology 42, 87-95, 2018 | 40 | 2018 |
A nucleus-like compartment shields bacteriophage DNA from CRISPR-Cas and restriction nucleases SD Mendoza, JD Berry, ES Nieweglowska, LM Leon, DA Agard, ... BioRxiv, 370791, 2018 | 10 | 2018 |
No 主観的健康感を中心とした在宅高齢者における 健康関連指標に関する共分散構造分析 Title SD Mendoza, ES Nieweglowska, S Govindarajan, LM Leon, JD Berry, ... Nat. Microbiol 3 (1), 641, 2020 | 9 | 2020 |
A minimal CRISPR-Cas3 system for genome engineering B Csörgő, LM León, IJ Chau-Ly, A Vasquez-Rifo, JD Berry, C Mahendra, ... bioRxiv, 860999, 2019 | 3 | 2019 |
CRISPR-Cas3: Studying the molecular interactions that drive adaptation & engineering novel bacterial editing tools LM Leon University of California, San Francisco, 2021 | 1 | 2021 |
334 Computational mapping of CAR-T cell exhaustion through single-cell perturbation screens L Wang, D DeTomaso, A Cass, J Chow, R Bao, AC Boroughs, A Cardozo, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
282 Improving solid tumor CAR-T therapies by modulating T cell transcriptional states using combinatorial in vitro CRISPR screening followed by in vivo validation LM Leon, AC Boroughs, A Cass, J Choe, A Cardozo, J Chow, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
Crispr-cas3 for making genomic deletions and inducing recombination LM Leon, B Csorgo, J Bondy-Denomy US Patent App. 17/621,669, 2022 | | 2022 |
A minimal CRISPR-Cas3 system for genome engineering [preprint] B Csörgő, LM León, IJ Chau-Ly, A Vasquez-Rifo, JD Berry, C Mahendra, ... | | 2019 |